ADAGE CAPITAL PARTNERS GP L.L.C. 13D and 13G filings for Aclaris Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-10 08:54 am Sale | 2021-12-31 | 13G | Aclaris Therapeutics, Inc. ACRS | ADAGE CAPITAL PARTNERS GP L.L.C. | 899,997 1.470% | -1,350,003 (-60.00%) | Filing |
| 2021-02-11 07:29 am Sale | 2020-12-31 | 13G | Aclaris Therapeutics, Inc. ACRS | ADAGE CAPITAL PARTNERS GP L.L.C. | 2,250,000 5.240% | -250,000 (-10.00%) | Filing |
| 2020-06-26 4:25 pm Purchase | 2020-06-17 | 13G | Aclaris Therapeutics, Inc. ACRS | ADAGE CAPITAL PARTNERS GP L.L.C. | 2,500,000 5.970% | 2,500,000 (New Position) | Filing |